Mark Burton
Primary Podiatric Medicine · Bristol, PANPI 1487659223
Payments from drug & device makers
What this record shows
This record is dominated by education: $122 of the $186 with a category attached, or 65.5%. Tactile Systems Technology Inc accounts for 65.5% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $161 and has fallen 91.3% since, to $14 in 2024. That places this record below the midpoint for primary podiatric medicine clinicians in PA, where the typical reported total is $554.
Across 5 payments — averaging $37.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tactile Systems Technology Inc$122
- Paragon 28, Inc.$20
- Merck$19
- Averitas Pharma Inc.$14
- Organogenesis Inc.$11
What the payments were for
- Food & beverage$6434%
- Education$12266%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tactile Systems Technology Inc | 1 | $122 |
| Paragon 28, Inc. | 1 | $20 |
| Merck | 1 | $19 |
| Averitas Pharma Inc. | 1 | $14 |
| Organogenesis Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLEXITOUCH$122
- ACTITOUCH$122
- ENTRE$122
How this compares
$186 in reported general payments places this provider in the 35th percentile of 31 primary podiatric medicine providers in Pennsylvania.
See all primary podiatric medicine providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 11 | $3,626 |
| Gabapentin | 228 | $2,214 |
| Terbinafine Hcl | 228 | $1,898 |
| Nystatin | 68 | $1,125 |
| Ammonium Lactate | 72 | $944 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 28 | $661 |
| Ibuprofen | 72 | $569 |
| Doxycycline Hyclate | 79 | $441 |
| Pregabalin | 23 | $326 |
| SsdSilver Sulfadiazine | 12 | $243 |
| Imiquimod | 13 | $236 |
| Alprazolam | 12 | $162 |
| Hydrocortisone | 27 | $151 |
| Methylprednisolone | 26 | $118 |
| Oxycodone Hcl | 21 | $100 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Bristol
- Donald MrdjenovichAltoona$26K
- Michael DowneyPhiladelphia$9K
- Paul GoehringBeaver Falls$5K
- Carl MattiaYardley$4K
- Louis GreerHarrisburg$3K
- Vincent PongiaCoatesville$3K
- Kenneth D'ortonePhiladelphia$2K
- Ketan KothariPhiladelphia$2K
- Gary CortesePottsville$1K
- Gerald GronborgMc Connellsburg$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.